- Career Center Home
- Search Jobs
- Senior Medical Science Liaison Movement Disorders - West
Description
The Senior Medical Science Liaison (Sr MSL), Movement Disorders provides advanced, field-based medical and scientific leadership in support of Lundbeck’s NeuroRare focus on multiple system atrophy. This role serves as a strategic pre-launch scientific partner to external experts and internal stakeholders, generating high-quality, actionable insights that inform evidence strategy, disease education, portfolio decision-making, and launch readiness.
The Sr MSL is expected to demonstrate outcome-oriented leadership, scientific depth, and insight generation that directly advances NeuroRare medical strategy, strengthens external scientific credibility, and shapes the disease environment.
ESSENTIAL FUNCTIONS:
Strategic Scientific Engagement & Insight Generation
- Establishes and sustains deep, longitudinal scientific partnerships with Key Opinion Leaders (KOLs), Centers of Excellence, and investigators working in multiple system atrophy.
- Serves as a trusted scientific expert through high-quality, compliant scientific exchange that advances understanding of disease biology, unmet need, endpoints, and emerging evidence.
- Acts as a primary generator of pre-launch actionable field medical insights by systematically testing scientific value narratives, differentiation hypotheses, and evidence gaps through external engagement.
- Synthesizes and communicates high-quality insights with clear implications for evidence strategy, publication planning, disease education, and portfolio-level decision-making.
- Ensures timely, accurate, and compliant documentation of insights in CRM systems in alignment with defined quality standards.
Evidence Strategy & Cross-Functional Partnership
- Partners closely with Medical Directors, Clinical Development, Evidence Strategy, and other cross-functional teams to align field execution with enterprise scientific priorities.
- Connects external experts internally to support advisory boards, evidence generation activities, publications, and strategic initiatives.
- Identifies and facilitates investigator-initiated trials (IITs), grant submissions, and research collaborations aligned with NeuroRare medical strategy.
- Supports clinical development activities, including investigator identification and site outreach, as appropriate and compliant.
Disease Education & Scientific Credibility
- Delivers impactful, non-promotional disease education that advances recognition, diagnosis, and referral pathways across NeuroRare indications.
- Ensures consistency, scientific rigor, and alignment of disease narratives and medical lexicon across field education activities.
- Supports congress strategy execution by engaging in high-value scientific discussions, attending priority sessions, and facilitating strategic KOL interactions with Medical Leadership.
- Maintains advanced knowledge of scientific and clinical developments in NeuroRare disease areas to inform education, insight generation, and evidence planning.
Field Medical Excellence
- Demonstrates scientific and behavioral leadership through role modeling of best-in-class MSL execution, engagement quality, and compliance.
- Actively contributes to Field Medical initiatives, workstreams, and process improvements that enhance scalability, quality, and impact.
- Serves as a mentor and onboarding resource for new MSLs, as assigned, supporting development toward independent, high-quality field execution.
- Completes all required training, administrative responsibilities, and documentation in accordance with Lundbeck policies and regulatory requirements on time.
- Maintains full compliance with FDA, company, and governance standards with no critical findings.
Requirements
REQUIRED EDUCATION, EXPERIENCE, AND SKILLS:
- Accredited advanced degree in a health or life sciences–related field.
- ≥5 years of healthcare or related experience (industry, clinical practice, research, academic, or managed markets).
- ≥2 years of customer-facing Field Medical Affairs experience within a pharmaceutical, biotech, or life sciences organization.
- Proven experience supporting pre-launch assets, including KOL identification, strategic mapping, trial site engagement.
- Demonstrated ability to interpret complex scientific data and translate insights into meaningful scientific dialogue and decision-relevant insights.
- Strong oral and written communication skills with the ability to influence without authority.
- Proven ability to build trust, lead through scientific credibility, and operate effectively in a matrixed environment.
- Track record of accountability, strategic thinking, and results orientation.
- Driving is an essential duty of this job; must have a valid driver’s license in good standing.
- The role is part of Lundbeck’s Vehicle Fleet Stipend Program and requires business use of a personal vehicle. More information on the stipend program can be found here.
PREFERRED EDUCATION, EXPERIENCE, AND SKILLS:
- Doctoral degree (MD, DO, PharmD, PhD), an accredited advanced clinical degree (NP or PA), or a master’s degree in a health sciences–related field.
- Experience and relationships in rare disease, Parkinson’s disease, neurodegenerative disorders, ataxia, autonomic disorders, or other related disease areas.
- Background in clinical practice, academic research, or teaching.
Rare Disease Capabilities and Leadership
- Trusted and respected voice within the rare disease ecosystem, known for transparency, empathy, and meaningful community engagement.
- Deep expertise in rare disease best practices.
- Highly proactive and solutions-oriented, capable of driving organizational progress in ambiguous or unstructured settings.
- Brings a mission-driven mindset — combining scientific rigor with empathy, credibility, and purpose to inspire cross-functional and external collaboration.
- Maintains a broad and influential network within the rare disease ecosystem, effectively mobilizing partnerships and coalitions to accelerate shared goals.
TRAVEL:
- Field-based position with willingness and ability to travel up to 50–75% domestically.